Katherine Levy
Apr 14, 2011

Novartis to review US$600m global media business

GLOBAL - Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated US$600 million global media business.

Novatris currently works with incumbent MEC
Novatris currently works with incumbent MEC

WPP's MEC is the incumbent on the global business.

In 2008 Novartis consolidated its US media planning and buying into MEC after moving its business from sibling agency Mindshare in a global realignment.

Novartis, which is headquartered in Basel, Switzerland, has three other businesses called Pharmaceuticals, Vaccines and Diagnostics, and Sandoz Generics, a global supplier of generic medicines that are produced after a popular medicine's patent has expired.

This article was first published on campaignlive.co.uk.

Source:
Campaign Asia

Related Articles

Just Published

12 minutes ago

M&C Saatchi details global rebrand and strategy ...

Rebrand will officially launch in March 2025 as the agency celebrates its 30th anniversary.

4 hours ago

'Measurement is the new currency': OMG APAC's Tony ...

As holding networks consolidate and AI reshapes the industry, Omnicom Media Group's APAC CEO talks about maintaining agency independence, China's future, weathering pitch losses, and why his biggest leadership lessons come far from the boardroom.

6 hours ago

Indonesia's VAT hike raises concerns about consumer ...

Consumer goods companies are preparing for a potential slowdown in sales as price-sensitive consumers reduce non-essential spending.

6 hours ago

Does your brand have the soul to succeed?

After shepherding billion-dollar brands at HP, Mars, and Unilever through an era where AI threatens to make marketing more mechanical than ever, veteran CMO Siew Ting Foo challenges conventional wisdom with a powerful argument: the future belongs to brands that dare to be human.